Letter to the Editor Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.46439/breastcancer.3.019
Metastatic breast cancer-derived exosomes and osteoclast-mediated bone metastasis
Manh Tien Tran1,*
- 1 Department of Medicine, University of Texas Health Science Center at San Antonio, TX 78229, USA
Corresponding Author
Manh Tien Tran, trant10@uthscsa.edu
Received Date: August 26, 2023
Accepted Date: September 05, 2023
Tran MT. Metastatic breast cancer-derived exosomes and osteoclast-mediated bone metastasis. J Breast Cancer Res. 2023;3(1):8-10.
Copyright: © 2023 Tran MT. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Probes for cancer metastasis imaging and therapeutic targeting
Metastasis of cancer is the process by which the primary tumor spreads from the original site to other parts of the body. Palliative care is the most common treatment option available for patients with metastatic cancer, but most patients eventually succumb to the disease due to the lack of therapeutics that can specifically target disseminated tumors [1].
HK2 fuels anoikis resistance to accelerate ICC metastasis
Intrahepatic cholangiocarcinoma (ICC), the second most frequent primary liver tumor, is a highly metastatic malignancy and often leads to disaster outcome in majority of patients, bringing significant challenges in the medical field [1].
FBXOing down V-ATPase: Implications for combating cancer metastasis
FBXO9, an evolutionarily conserved member of the F-box protein family, functions as a substrate receptor within the Cullin 1-RING ubiquitin ligase complex (CRL1), also known as the SKP1-Cullin 1-F-box (SCF) complex [1].
Breast cancer: an up-date review
Breast cancer is the second most common cancer in the world and the most common cancer among women. The most common presenting symptoms are a painless subareolar lump, nipple retraction, and bleeding from the nipple.
How to inhibit breast cancer and breast cancer metastasis with Akt inhibitors: Lessons learned from studies in mice
The PI3K/Akt signaling pathway is frequently hyperactivated in different types of breast cancer. In the past two decades, major efforts have been made to develop inhibitors of this pathway to treat cancer patients.